A Comprehensive Review of Specific Herbal Medicines
with Immunomodulatory Effects, and COVID-19

Nicholas A Kerna1,2*, Joseph Anderson II3, Kevin D Pruitt4,5, Hilary M Holets6,7, ND Victor Carsrud8, Raymond Nomel9,
Uzoamaka Nwokorie10 and John V Flores6,7

Review Article

Volume 4 Issue 12 - 2021

A Comprehensive Review of Specific Herbal Medicines with Immunomodulatory Effects, and COVID-19

Nicholas A Kerna^1,2*, Joseph Anderson II³, Kevin D Pruitt^4,5, Hilary M Holets^6,7, ND Victor Carsrud⁸, Raymond Nomel⁹, Uzoamaka Nwokorie¹⁰ and John V Flores^6,7

¹SMC–Medical Research, Thailand

²First InterHealth Group, Thailand

³International Institute of Original Medicine, USA

⁴Kemet Medical Consultants, USA

⁵PBJ Medical Associates, LLC, USA

⁶Beverly Hills Wellness Surgical Institute, USA

⁷Orange Partners Surgicenter, USA

⁸Lakeline Wellness Center, USA

⁹All Saints University, College of Medicine, St. Vincent and the Grenadines

¹⁰University of Washington, USA

*Corresponding Author: Nicholas A Kerna, (mailing address) POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.

Received: September 21, 2021; Published: November 30, 2021

Abstract

In contemporary times, herbal medicine is used as an adjunct to conventional therapy and for health promotion. Herbs that have long been considered curative or prophylactic should be further studied in clinical trials. Can these time-tested natural therapies be used and trusted in exceptional circumstances, such as the ongoing COVID-19 pandemic?

Traditional medicines have led to a revolution in and evolution of modern medicine. Herbs, such as Echinacea purpurea, Curcuma longa, Allium sativum, Althaea officinalis, Andrographis paniculate, Commiphora molmol, Cymbopogon citratus, Eucalyptus globulus, have shown immunomodulatory effects. Many plant-based formulations with potential immunomodulatory activity have been isolated and utilized—even without supportive evidence-based findings. Thus, more initiative toward human trials should be undertaken to understand better how herbs promote human health and prevent or cure specific illnesses and diseases.

Moreover, and most importantly, the interests of indigenous communities—which are the primary source of rich traditional knowledge and the natural reserve of herbal plants—should be safeguarded.

Keywords: Mangosteen; Natural Remedy; Phytotherapeutic; Thai; Traditional; Vedas

References

Introduction and Importance of Medicinal Plants and Herbs (2021).https://www.nhp.gov.in/introduction-and-importance-of-medicinal-plants-and-herbs_mtl
Stojanoski N. “Development of health culture in Veles and its region from the past to the end of the 20th century”. Veles: Society of science and art (1999): 13-34.
Sharma P., et al. “Immunomodulators: Role of medicinal plants in the immune system”. National Journal of Physiology, Pharmacy and Pharmacology 6 (2017): 552-556. http://njppp.com/fulltext/28-1487571016.pdf
Calixto JB. “Efficacy, safety, quality control, marketing, and regulatory guidelines for herbal medicines (phytotherapeutic agents)”. The Brazilian Journal of Medical and Biological Research 2 (2000). https://pubmed.ncbi.nlm.nih.gov/10657057/
BB Petrovska. “Historical review of medicinal plants’ usage”. Pharmacognosy Reviews 11 (2012): 1-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358962/
Ekor M. “The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety”. Frontiers in Pharmacology 4 (2013): 177. https://pubmed.ncbi.nlm.nih.gov/24454289/
Kelly K. “History of medicine”. New York: Facts on file (2009): 29-50.
Thorwald J. “Power and knowledge of ancient physicians”. Zagreb: August Cesarec (1991): 10-255.
Haddad PS., et al. “Natural health products, modulation of immune function and prevention of chronic diseases”. Evidence-Based Complementary and Alternative Medicine 4 (2005): 513-520. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297498/
Singh N. “A Review On Herbal Plants Used As Immunomodulators”. International Journal of Pharmaceutical Research 02 (2021): 3602-3610. http://www.ijpronline.com/ViewArticleDetail.aspx?ID=20830
Xiao C., et al. “Medical Plants and Immunological Regulation”. Journal of Immunology Research Volume (2018). https://www.hindawi.com/journals/jir/si/694170/
Davis L and Kuttan G. “Immunomodulatory activity of Withania somnifera”. Journal of Ethnopharmacology 71 (2000): 193-200. https://pubmed.ncbi.nlm.nih.gov/10904163/
Singh UP., et al. “Role of garlic (Allium sativum L.) in human and plant diseases”. Indian Journal of Experimental Biology 4 (2001): 310-322. https://pubmed.ncbi.nlm.nih.gov/11491574/
Liu P., et al. “Chemical constituents, biological activity and agricultural cultivation of Aloe vera- A review”. Asian Journal of Chemistry 112 (2013): 6477. http://www.asianjournalofchemistry.co.in/User/ViewFreeArticle.aspx?ArticleID=25_13_1
Thakur M., et al. “Immunomodulatory activity of Chlorophytum borivilianum Sant. F”. Evidence-Based Complementary and Alternative Medicine4 (2007): 419-423. https://pubmed.ncbi.nlm.nih.gov/18227908/
Boskabady MH., et al. “The effects of Curcuma Longa L. and its constituents in respiratory disorders and molecular mechanisms of their action”. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Edition. Elsevier: Oxford, UK 65 (2020): 239-269. https://www.researchgate.net/publication/342401858_The_effects_of_Curcuma_Longa_L_and_its_constituents_in_respiratory_disorders_and_molecular_mechanisms_of_their_action
Sharma MSA., et al. “Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract”. Antiviral Research2 (2009): 165-170. https://pubmed.ncbi.nlm.nih.gov/19409931/
Rattis BAC., et al. “Curcumin as a Potential Treatment for COVID-19”. Frontiers in Pharmacology 12 (2021): 1-14. https://pubmed.ncbi.nlm.nih.gov/34025433/
Valizadeh H., et al. “Nano-curcumin Therapy, a Promising Method in Modulating Inflammatory Cytokines in COVID-19 Patients”. International Immunopharmacology 89 (2020): 107088. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574843/
Burger RA., et al. “Echinacea-induced cytokine production by human macrophages”. International Journal of Immunopharma- Cology7 (1997): 371-379. https://pubmed.ncbi.nlm.nih.gov/9568541/
Back AT and Lundkvist A. “Dengue viruses-an an overview”. Infection Ecology and Epidemiology 3 (2013): 19839. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759171/
Pu WL., et al. “Anti-inflammatory effects of Rhodiola rosea L.: A review”. Biomedicine and Pharmacotherapy 121 (2020): 109552. https://pubmed.ncbi.nlm.nih.gov/31715370/
Aucoin M., et al. “The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review”. Advances in Integrative Medicine 4 (2020): 203-217. https://pubmed.ncbi.nlm.nih.gov/32837894/
Silveira D., et al. “COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?” Frontiers in Pharmacology 11 (2020): 1-44. https://www.frontiersin.org/articles/10.3389/fphar.2020.581840/full
EMA (2016c). “European Union herbal monograph on Althaea officinalis L., radix,” in EMA/HMPC/436679/2015 Committee on Herbal Medicinal Products (HMPC) (London: European Medicines Agency) (2016c). https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-althaea-officinalis-l-radix_en.pdf
Monographs on selected medicinal plants 2 (Geneva: World Health Organization) (2002). http://apps.who.int/iris/bitstream/handle/10665/42052/9241545178.pdf;jsessionid=BC0DFB602E5A4372D83467D9025036EC?sequence=1
Su S., et al. “Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha”. Journal of Ethnopharmacology 134 (2011): 251-258. https://pubmed.ncbi.nlm.nih.gov/21167270/
Silva FFM., et al. “Analysis of chemical composition of the essential oil of holy grass (Cymbopogon citratus) obtained through extractor for water vapor trail with built with materials of acquisition and easy low cost”. Holos 30 (2014): 144. https://www.proquest.com/docview/1612531245
HHDC (2018). Information on Ethnic Group Populations in 20 Provinces (In Thai) (2021).
Phumthum M., et al. “Medicinal Plants Used for Treating Mild Covid-19 Symptoms Among Thai Karen and Hmong”. Frontiers in Pharmacology 12 (2021): 699897. https://www.frontiersin.org/articles/10.3389/fphar.2021.699897/full
Shi TH., et al. “Andrographolide and its Fluorescent Derivative Inhibit the Main Proteases of 2019-nCoV and SARS-CoV through Covalent Linkage”. Biochemical and Biophysical Research Communications 3 (2020): 467-473. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447262/
Khorrami S., et al. “Sesame seeds essential oil and Sesamol modulate the pro-inflammatory function of macrophages and dendritic cells and promote Th2 response”. The Medical Journal of the Islamic Republic of Iran 1 (2018): 1-8. https://pubmed.ncbi.nlm.nih.gov/30788333/
Pathak N., et al. “Value addition in sesame: A perspective on bioactive components for enhancing utility and profitability”. Pharmacognosy Reviews 16 (2014): 147-155. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127822/
Kanjanasirirat P., et al. “High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents”. Scientific Reports 1 (2020): 1-12. https://pubmed.ncbi.nlm.nih.gov/33203926/
Hu XY., et al. “Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis”. PLoS One8 2(2017): e0181780. https://pubmed.ncbi.nlm.nih.gov/28783743/
Andrographis paniculata (Burm. F.) Wall. Ex Nees, Andrographolide, and Andrographolide Analogues as SARS-CoV-2 Antivirals? A Rapid Review Xin Yi Lim, Janice Sue Wen Chan, Terence Yew Chin Tan et al”. Natural Product Communications5 (2021): 1-15. https://journals.sagepub.com/doi/full/10.1177/1934578X211016610
Pedraza-Chaverri J., et al. “Medicinal properties of mangosteen (Garcinia mangostana)”. Food and Chemical Toxicology 46 (2008): 3227-3239. https://pubmed.ncbi.nlm.nih.gov/18725264/
Tang YP., et al. “Effect of a mangosteen dietary supplement on human immune function: a randomized, double-blind, placebo-controlled trial”. Journal of Medicinal Food 4 (2009): 755-763. https://pubmed.ncbi.nlm.nih.gov/19697997/
Balekundri A and Mannur VK. “Quality control of the traditional herbs and herbal products: a review”. Future Journal of Pharmaceutical Sciences 6 (2020): 67. https://fjps.springeropen.com/articles/10.1186/s43094-020-00091-5
Quality control methods for herbal materials (2011).
Che CT., et al. “Herb-Herb Combination for Therapeutic Enhancement and Advancement: Theory, Practice, and Future Perspectives”. Molecules5 (2013): 5125-5141. https://pubmed.ncbi.nlm.nih.gov/23644978/
Lou SK., et al. “An integrated web medicinal materials DNA database: MMDBD (Medicinal Materials DNA Barcode Database)”. BMC Genomics 11 (2010): 402. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996930/
Myers N. “The world's forests and human population: the environmental interconnections”. Population and Development Review 16 (1991): 1-15. https://www.jstor.org/stable/2808073
Farooquee NA., et al. “Indigenous knowledge systems and sustainable management of natural resources in a high altitude society in Kumaun Himalaya, India”. Journal of Human Ecology 16 (2004): 33-42. https://www.tandfonline.com/doi/abs/10.1080/09709274.2004.11905713
Kala CP., et al. “Developing the medicinal plants' sector in northern India: challenges and opportunities”. Journal of Ethnobiology and Ethnomedicine 2 (2006): 32. https://ethnobiomed.biomedcentral.com/articles/10.1186/1746-4269-2-32
State of the World's Forest. Rome: Food and Agricultural Organization (2003). https://www.fao.org/3/y7581e/y7581e.pdf
Bulletin 350. Royal Tropical Institute, Amsterdam, The Netherlands; 2003. Cultivating a Healthy Enterprise (2003).
Kala CP. “Assessment of species rarity”. Current Science 86 (2004): 1058-1059.
Hamilton AC. “Medicinal plants, conservation and livelihoods”. Biodiversity and Conservation 13 (2004): 1477-1517. https://link.springer.com/article/10.1023/B:BIOC.0000021333.23413.42
Schippmann U., et al. “Impact of cultivation and Gathering of Medicinal Plants on Biodiversity: Global Trends and Issues. Rome: Inter-Department Working Group on Biology Diversity for Food and Agriculture, FAO (2002). https://www.fao.org/3/AA010E/AA010e00.htm
Rao MR., et al. “Medicinal and aromatic plants in agroforestry systems”. Agroforestry Systems 61 (2004): 107-122. https://www.researchgate.net/publication/226462494_Medicinal_and_aromatic_plants_in_agroforestry_systems
Koo B., et al. “Intellectual property. Plants and intellectual property: an international appraisal”. Science5700 (2004): 1295-1297. https://pubmed.ncbi.nlm.nih.gov/15550646/
Karimi A., et al. “Herbal versus synthetic drugs; beliefs and facts”. Journal of Nephropharmacology 1 (2015): 27-30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297475/
Izzo AA. “Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data”. Medical Principles and Practice 21 (2012): 404-428. https://pubmed.ncbi.nlm.nih.gov/22236736/
Lee A., et al. “Possible interaction between sevoflurane and Aloe vera”. Annals of Pharmacotherapy 38 (2004): 1651-1654. https://pubmed.ncbi.nlm.nih.gov/15292490/
López Galera RM., et al. “Interaction between cat’s claw and protease inhibitors atazanavir, ritonavir and saquinavir”. European Journal of Clinical Pharmacology 64 (2008): 1235-1236. https://pubmed.ncbi.nlm.nih.gov/18712519/
Hajda J., et al. “Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans”. European Journal of Pharmaceutical Sciences 41 (2010): 729-735. https://www.researchgate.net/publication/47382303_Garlic_extract_induces_intestinal_P-glycoprotein_but_exhibits_no_effect_on_intestinal_and_hepatic_CYP3A4_in_humans
Taylor JR and Wilt VM. “Probable antagonism of warfarin by green tea”. Annals of Pharmacotherapy 33 (1999): 426-428. https://pubmed.ncbi.nlm.nih.gov/10332534/
Werba JP., et al. “The effect of green tea on simvastatin tolerability”. Annals of Internal Medicine 149 (2008): 286-287. https://pubmed.ncbi.nlm.nih.gov/18711168/
Guidelines on good agricultural and collection practices (GACP) for medicinal plants. WHO guidelines on good agricultural and collection practices. Geneva GACP 1-71 (2003). http://apps.who.int/iris/bitstream/handle/10665/42783/9241546271.pdf?sequence=1
WHO Traditional Medicine Strategy 2014-2023. Traditional Medicine Strategy 2019 (2021). https://www.who.int/publications/i/item/9789241506096
Guidelines for ATC classification and DDD assignment 2013. WHO Collaborating Centre for Drug Statistics Methodology”. Drug Statistics Methodology (2012). https://www.whocc.no/filearchive/publications/1_2013guidelines.pdf
Geneva: WHO Library Cataloguing-in-Publication Data, World Health Organization; 2005. [Last cited on 2014 Apr 29]. Guidelines on the Registration of Traditionally used Herbal Products, Department of Health, Republic of Philippines, Report of a WHO Global Survey (2021). https://apps.who.int/iris/bitstream/handle/10665/92455/9789241506090_eng.pdf
Malik V, editor. 23^rd Lucknow: Eastern Book Company. Law Relating to Drugs and Cosmetics (2013).
Ishak R and Mohamad J. “Guidelines on Registration of Traditional and Health Supplement Products”. Revised ed. Version 1.0. Kuala Lumpur. Malaysian Biotechnology Corporation SDN BH (2011). http://www.biotechcorp.com.my/wp.content/uploads/2011/11/guidelines-on-registration-of-traditional-health-supplement-product-Dec-2011-Revision.pdf
Health Sciences Authority. Regulatory guidelines (2021). https://www.hsa.gov.sg/docs/default-source/hprg-tpb/guidances/guidance-on-therapeutic-product-registration-in-singapore_aug21.pdf
Ramadoss MSK and Koumaravelou K. “Regulatory compliance of herbal medicines–A review”. International Journal of Research in Pharmaceutical Sciences 4 (2019): 3127-3135. https://pharmascope.org/index.php/ijrps/article/view/1609

Citation: Kerna NA, Anderson II J, Pruitt KD, Holets HM, Carsrud NDV, Nomel R, Nwokorie U, Flores JV. ““A Comprehensive Review of Specific Herbal Medicines with Immunomodulatory Effects, and COVID-19”. EC Clinical and Medical Case Reports 4.12 (2021): 50-62.

Copyright: © 2021 Nicholas A Kerna., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.